Please login to the form below

Not currently logged in
Email:
Password:

UK biotech body the BIA appoints Steve Bates as CEO

The former APCO director has experience in biotech with Genzyme and government as Labour adviser

Steve Bates - BIA BioIndustry AssociationThe UK's BioIndustry Association (BIA) has named the director of public affairs firm APCO Steve Bates (pictured) as its new CEO.

He will take up his new role on July 2 and replace Glyn Edwards, who has the led the bioscience trade body on an interim basis since November, 2011.

Bates had only been in his present role at APCO since the beginning of the year having previously served at Genzyme as its senior director external affairs and market access, Commonwealth and Ireland from March 2010 to January 2012.

During this time, he worked on the establishment of the government's Office for Life Science and was a member of the BIA's Communications Advisory Committee.

He initially joined biotech Genzyme in 2008 to serve as government relations director for the UK and Ireland.

This move followed several years spent working as special adviser to the UK's Labour government when it was in power. Bates' time working for Labour included advising John Reid when he was the country's Health Secretary.

“We are delighted that Steve is joining the BIA,” said BIA chair Tim Edwards. “I am certain that his experience in the bioscience sector and within government will prove to be invaluable.”

Part of Bates' remit will be to campaign for the introduction of the BIA's much-championed Citizens Innovation Fund, which would allow individuals make a tax-free investment of up to £15,000 a year in innovative businesses.

“UK bioscience is at the heart of the new global economy,” said Bates. “The sector's talented and visionary researchers, developers and executives are producing the treatments and innovations to help patients in the future.

“Having worked both in government and biotech I know how to be an effective voice for the sector and look forward to working in partnership with government, academia and the health service to enable bioscience companies in the UK to succeed.”

26th June 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

Porterhouse Medical provides medical and scientific communication services to the pharmaceutical industry across the globe, with a focus on solutions...

Latest intelligence

Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...
Deal Watch January 2018
...
Emotional Intelligence and Blended Learning in Healthcare
EI and emotional selling are rising up the agenda when it comes to healthcare training. This article outlines how blended learning approaches can help put them into action....

Infographics